Pfizer Anti-competitive Conduct | Gilbert + Tobin Lawyers

24/02/2014

Simon Snow, Partner, discusses the anti-competitive conduct charges against Pfizer by the ACCC.

Expertise Area

Our COVID-19 hub collates important articles and legal advice on various aspects of COVID-19 on how it may impact your business.

Recommended Knowledge

01/07/2020

Open Banking turns the lights on

Today, the Australian Competition and Consumer Commission (ACCC) officially switches on the Consumer Data Right (CDR) regime, implemented in the banking…

Expertise Area

29/06/2020

Global competition and antitrust regulators to focus on use of data

The International Competitive Network (ICN) is the eminent group of competition authorities from over 130 jurisdictions. The ICN published a scoping paper…

Expertise Area

03/06/2020

ACCC to develop a mandatory code for digital platforms to pay for

In a joint ann

Expertise Area

28/05/2020

Bypassing mutual assistance – the International Production Orders

Just prior to the Federal Government having to turn all of its attention to preventing the spread of COVID-19 in Australia, it

Expertise Area

29/04/2020

Your COVID-19 Response: Managing consumer law obligations

The unprecedented health and economic issues arising from the pandemic are putting intense pressure on dealings between businesses and consumers and other…

Expertise Area

29/04/2020

Your COVID-19 Response: Managing competition law obligations

The world is grappling with an unprecedented health and economic crisis.

Expertise Area